0000000000490242

AUTHOR

Sławomir Dobrzycki

showing 3 related works from this author

Decline in the number of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Polan…

2020

medicine.medical_specialtyTime FactorsCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentPneumonia ViralMyocardial InfarctionCoronary AngiographyPercutaneous Coronary InterventionInternal medicineAngioplastyPandemicmedicineHumansIn patientMyocardial infarctionDisease management (health)Angioplasty Balloon CoronaryPandemicsbusiness.industryPercutaneous coronary interventionCOVID-19Disease Managementmedicine.diseasePneumoniaCardiologyPolandCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsKardiologia polska
researchProduct

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, p…

2021

The risk of ischemic events gradually decreases after acute coronary syndrome (ACS), reaching a stable level after 1 month, while the risk of bleeding remains steady during the whole period of dual antiplatelet treatment (DAPT). Several de-escalation strategies of antiplatelet treatment aiming to enhance safety of DAPT without depriving it of its efficacy have been evaluated so far. We hypothesized that reduction of the ticagrelor maintenance dose 1 month after ACS and its continuation until 12 months after ACS may improve adherence to antiplatelet treatment due to better tolerability compared with the standard dose of ticagrelor. Moreover, improved safety of treatment and preserved anti-is…

Acute coronary syndromemedicine.medical_specialtyELECTRA-SIRIO 2TicagrelorClinical CardiologyPlaceboantiplatelet therapylaw.inventionacute coronary syndrometicagrelorClinical studyPercutaneous Coronary InterventionRandomized controlled triallawInternal medicinemedicineHumansAcute Coronary SyndromeAspirinbusiness.industryMaintenance doseGeneral Medicinemedicine.diseasede-escalationTolerabilityELECTRA-SIRIO 2 ; acute coronary syndrome ; antiplatelet therapy ; de-escalation ; ticagrelorCardiologyCardiology and Cardiovascular MedicinebusinessTicagrelorDe-escalationPlatelet Aggregation Inhibitorsmedicine.drug
researchProduct

Effects of the coronavirus disease 2019 pandemic on the number of hospitalizations for myocardial infarction: regional differences. Population analys…

2020

2019-20 coronavirus outbreakCardiac CatheterizationCoronavirus disease 2019 (COVID-19)PopulationPneumonia ViralMyocardial InfarctionBetacoronavirusPandemicmedicineHumansMyocardial infarctionCoronary Artery BypasseducationPandemicseducation.field_of_studybiologybusiness.industrySARS-CoV-2COVID-19Length of Staybiology.organism_classificationmedicine.diseaseHospitalizationPneumoniaCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsBetacoronavirusRegional differencesDemographyKardiologia Polska
researchProduct